Search For "glenmark pharmaceuticals"
Glenmark Pharmaceuticals receives sANDA approval for Tacrolimus Ointment,
Updated : 2 years, 7 months ago IST
Mumbai (Maharashtra) [India]/ Mahwah (New Jersey) [US], August 17: Glenmark Pharmaceuticals Ltd. (Glenmark), a research-led, integrated, global pharmaceutical company has received the final approval from the United States Food & Drug Administration (U.S. FDA) for Tacrolimus Ointment, 0.0
Read More
Glenmark Pharma reports revenue growth of 22.5 per cent, EBITDA growth of
Updated : 2 years, 7 months ago IST
Mumbai (Maharashtra) [India], August 12: Glenmark Pharmaceuticals Limited (Glenmark), an integrated, research-led, global pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2023.
Read More
Glenmark Pharma and OMRON Healthcare India team up to combat hypertension
Updated : 2 years, 7 months ago IST
Mumbai (Maharashtra) [India], August 3: Glenmark Pharmaceuticals Limited (Glenmark), a leading, integrated, research-led, global pharmaceutical company has joined hands with OMRON Healthcare India, the Indian arm of the Japanese global leader in home blood pressure monitoring and solutions f
Read More
Trade turnover between India, Dominican Republic has reached about USD 1 b
Updated : 2 years, 11 months ago IST
Addressing the India-Dominican Republic Business Event in the Dominican Republic, Jaishankar said, "So this is very much, therefore, a diplomatic trip. It is a political trip, but it is, ofcourse, a business trip. Where the Dominican Republic is concerned from a trade we had of USD 12 mil
Read More
Glenmark launches injection for prevention of chemotherapy-induced nausea,
Updated : 3 years, 2 months ago IST
It is a fixed-dose combination of fosnetupitant (235 mg) and palonosetron (0.25 mg), and is available as a ready-to-dilute IV injection. It is administered as a single infusion 30 minutes prior to the start of each chemotherapy cycle that helps prevent, both, acute and delayed phases of CINV
Read More
Glenmark launches drug for treating type 2 diabetes
Updated : 3 years, 3 months ago IST
This fixed-dose combination has been launched under the brand name Zita-PioMet, and contains Teneligliptin (20 mg), Pioglitazone (15 mg) and Metformin (500mg/1000mg) in a sustained release (SR) formulation, according to the company's statement. It offers patients with type 2 diabetes the con
Read More
Glenmark gets US drug regulator's nod for high BP medicine
Updated : 3 years, 3 months ago IST
Glenmark's Nicardipine Hydrochloride capsules of 20 mg and 30 mg will be distributed in the US by Glenmark Pharmaceuticals US, according to a statement from Glenmark.
Read More
Hikma launches RYALTRIS™ seasonal allergic rhinitis nasal spray in t
Updated : 3 years, 6 months ago IST
London [UK]/ Mahwah (New Jersey) [US], Mumbai (Maharashtra) [India], August 31 (ANI/PRNewswire): Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical company, and Glenmark Specialty S.A., a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark) - an innovation driven gl
Read More
Glenmark Pharma reports revenue of Rs 27,773 Mn and PAT of Rs 2,111 Mn for
Updated : 3 years, 7 months ago IST
Mumbai (Maharashtra) [India], August 11 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd. (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the first quarter ended June 30, 2022.
Read More
Glenmark announces Peer Reviewed Publication of Its Phase 3 Clinical Trial
Updated : 3 years, 8 months ago IST
Mumbai (Maharashtra) [India]/ Vancouver [BC], July 13 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company, and SaNOtize Research and Development Corp, today announced that The Lancet Regional Health Southeast Asia (TLRHSEA) - pee
Read More
Glenmark launches sitagliptin and its fixed-dose combinations, at affordab
Updated : 3 years, 8 months ago IST
Mumbai (Maharashtra) [India], July 8 (ANI/PRNewswire): Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company has launched sitagliptin and its Fixed Dose Combinations (FDCs), at affordable prices for adults with Type 2 diabetes in India. The company h
Read More
Glenmark Pharmaceuticals Inc., USA continues to expand its Over-The-Counte
Updated : 3 years, 9 months ago IST
Mumbai (Maharashtra) [India]/ Mahwah (New Jersey) [US], June 28 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd., an innovation-driven, global pharmaceutical company, announced that its fully owned subsidiary Glenmark Pharmaceuticals Inc., USA (Glenmark) has acquired the approved Abbreviated
Read More